Atara Biotherapeutics (ATRA) Raw Materials (2022 - 2024)

Atara Biotherapeutics has reported Raw Materials for 3 years, with the latest figure at $964000.0 in Q4 2024.

• For the quarter ending Q4 2024, Raw Materials fell 58.72% year-over-year to $964000.0; the trailing twelve-month figure through Dec 2024 stood at $964000.0 (down 58.72% YoY), and the FY2024 full-year result was $964000.0, down 58.72% from the prior year.
• Raw Materials for Q4 2024 stood at $964000.0, down from $1.7 million in the prior quarter.
• The five-year high for Raw Materials was $4.4 million in Q1 2024, with the low at $964000.0 in Q4 2024.
• Historically, Raw Materials has averaged $2.3 million across 3 years, with a median of $2.3 million in 2023.
• The largest YoY upside for Raw Materials was 229.38% in 2024 against a maximum downside of 58.72% in 2024.
• Atara Biotherapeutics' Raw Materials stood at $1.2 million in 2022, then surged by 92.34% to $2.3 million in 2023, then plunged by 58.72% to $964000.0 in 2024.
• The last three Raw Materials figures came in at $964000.0 (Q4 2024), $1.7 million (Q3 2024), and $3.6 million (Q2 2024), per Business Quant data.